| pubmed-article:19067930 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C0162371 | lld:lifeskim |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C0039730 | lld:lifeskim |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C0439148 | lld:lifeskim |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C1262018 | lld:lifeskim |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C0935850 | lld:lifeskim |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C0599346 | lld:lifeskim |
| pubmed-article:19067930 | lifeskim:mentions | umls-concept:C0445356 | lld:lifeskim |
| pubmed-article:19067930 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19067930 | pubmed:dateCreated | 2009-8-20 | lld:pubmed |
| pubmed-article:19067930 | pubmed:abstractText | Early GF is a frequent complication following hematopoietic stem cell transplantation for patients with thalassemia. We report the outcome of double-unit CBT in three patients who developed early GF after CBT. The initial conditioning regimen consisted of i.v. Bu 14 mg/kg (day -9 to -6), i.v. Cy 200 mg/kg (day -5 to -2) and ATG at 120 mg/kg (day -4 to -1). They received GVHD prophylaxis with cyclosporine-A from day -3 and a short course of methylprednisolone (1 mg/kg i.v., every 12 h on days 5-19 with a taper, thereafter 25% decrease every other day). The interval between two transplants was seven and 10 months. The retransplant recipients were preconditioned with i.v. Bu 14 mg/kg (day -7 to -4), i.v. Cy 120 mg/kg (day -3 to -2) and ATG at 150 mg/kg (day -5 to -1 and +1 to +5). GVHD prophylaxis regimen was the same as the first transplant. Neutrophil engraftment were observed in all patients between day +15 and +26. All are alive, between nine and 11 months after retransplant. Our group reported successful utilization of double umblical cord blood grafts in thalassemia patients with early GF. | lld:pubmed |
| pubmed-article:19067930 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19067930 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19067930 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19067930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19067930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19067930 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19067930 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19067930 | pubmed:issn | 1399-3046 | lld:pubmed |
| pubmed-article:19067930 | pubmed:author | pubmed-author:SunChien-Feng... | lld:pubmed |
| pubmed-article:19067930 | pubmed:author | pubmed-author:HungIou-JihIJ | lld:pubmed |
| pubmed-article:19067930 | pubmed:author | pubmed-author:YangChao-Ping... | lld:pubmed |
| pubmed-article:19067930 | pubmed:author | pubmed-author:JaingTang-Her... | lld:pubmed |
| pubmed-article:19067930 | pubmed:author | pubmed-author:LeeWen-IWI | lld:pubmed |
| pubmed-article:19067930 | pubmed:author | pubmed-author:TsaiMing-Horn... | lld:pubmed |
| pubmed-article:19067930 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19067930 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:19067930 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19067930 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19067930 | pubmed:pagination | 766-8 | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:meshHeading | pubmed-meshheading:19067930... | lld:pubmed |
| pubmed-article:19067930 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19067930 | pubmed:articleTitle | Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia. | lld:pubmed |
| pubmed-article:19067930 | pubmed:affiliation | Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan. | lld:pubmed |
| pubmed-article:19067930 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19067930 | pubmed:publicationType | Case Reports | lld:pubmed |
